2012, Number 2
PDF size: 122.01 Kb.
ABSTRACTBackground: abortion is the expulsion of a human fetus when it is not yet able to survive outside the womb.
Objective: to compare clinical and economic effectiveness of misoprostol as a method of termination of pregnancy with the traditional method.
Method: a descriptive, cross-sectional study was conducted at the University Hospital Manuel Piti Fajardo, Florida Camagüey, from January to December 2010. The universe was constituted by 600 patients who came to family planning consultation; the sample was made up 450 pregnants which met the inclusion criteria. Data were collected and processed in computerized form, as statistical measures, numbers and percents.
Results: this method was considered effective because comprehensive abortion was achieved without requiring surgical procedure. Comprehensive abortion occurred at 409 patients, 41 failures were presented in the first cycle, 19 patients were applied a second dose and the 22 remaining surgical method was applied to them, the method was more effective with the first cycle in 390 patients. With the implementation of non-surgical method, there was a saving in the budget of $16793.54.
Conclusions: the most common side effects after the use of this method were chills, nausea, and pelvic pain, the largest number of patients achieved comprehensive abortion with the use of vaginal misoprostol in the first cycle where the number of failures was unrepresentative. With the implementation of the pharmacological method, there was a saving in the budget compared to surgical abortion.
Socarras IN, Medina MP. Enfermería ginecobstetrica. La Habana: Editorial Ciencias Médicas; 2009.
Personal communication with Helena von Hertzen. Ginebra: WHO; 2005.
Cullen M. Important drug warning concerning unapproved use of intravaginal or oral misoprostol in pregnant women for induction of labor abortion. St. Louis: Skokie, IL Searle; 2006.
Blanchard K, Clark S, Winikoff B, Gaines G, Kabani G, Shannon C. Misoprostol for women´s health: a review. Obst Gynecol. 2008; 99(2):316-32.
Shannon CS, Winikoff B. Misoprostol: An Emerging Technology for Womens Health. Report of a Seminar. New York: Population Council; 2006.
Blanchard K, Winikoff B, Ellertson. Misoprostol use alone for termination of early pregnancy: a review of the evidence. Contraception. 2006; 59(4):209-17.
Zieman M, Fong SK,Benowitz NL, Banker D. Aborption Kinetics of misoprostol with oral or vaginal administration. Obst Gynecol. 2005; 90(1):88-92.
World Health Organization (WHO). Safe Abortion: Technical and Policy Guidance for Health Systems. Geneva: WHO; 2006.
Jain JK, Dutton C, Harwood B, Meckstroth KR,Mishell DR Jr. A prospective randomized, double blinded, placebo controlled trial comparing mifepristone and vaginal misoprostol alone for elective termination of early pregnancy. Hum Reprod. 2005; 17(6):1477-82.
Goldberg AB, Greenberg MB, Darney PD. Misoprostol and pregnancy. New Eng J Med. 2007; 344(1):38-47.
Costa SH. Commercial availability of misoprostol and induced abortion in Brazil. Int J Gynecol Obst. 2000; 63(Suppl 1):5131-9.
Ngoc NT, Blum J, Wertheimer E, Quan TT, Winikoff B. Medical treatment of missed abortion using misoprostol. Int J Gynecol Obst. 2006; 87(2):138-42.
Norman J E, Thong K J, Baird T D. Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristona. The Lancet. 1996;338:1233-6.
Grimes Cates W. Complications from legally induced abortions: a review. Obst Gynecol Surv. 2002; 34:177-191.
Cameron T, Baird DT. Early pregnancy termination: A comparison between vacuum aspiration and medical abortion using prostaglandin or antiprogestagen RU 486. Br J Obst Gynecol. 2007; 95:271-6.
Nápoles SM. El aborto inducido del primer trimestre. El estudio epidemiológico preliminar. La Habana: Editorial Ciencias Médicas; 2008.
Agoestina T. Evaluation of gametoprost vaginal pessañes in the termination of abnormal intrauterine pregnancies at twelve teaching hospitals in Indonesia. Exc Ginecol Obst. 2006; 45(7):45-57.